[1]王学宗,郑昱新,曹月龙,等.柔肝和化痰中药复方对膝骨关节炎患者关节功能及关节液软骨寡聚基质蛋白浓度的影响[J].中医正骨,2014,26(01):17-20.
 Wang Xuezong*,Zheng Yuxin,Cao Yuelong,et al.Effect of nourishing liver compounds(TCD)and expelling phlegm compounds(TCD)on knee joint function and the synovial fluid concentration of cartilage oligomeric matrix protein in patients with knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(01):17-20.
点击复制

柔肝和化痰中药复方对膝骨关节炎患者关节功能及关节液软骨寡聚基质蛋白浓度的影响()
分享到:

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第26卷
期数:
2014年01期
页码:
17-20
栏目:
骨关节炎
出版日期:
2014-01-28

文章信息/Info

Title:
Effect of nourishing liver compounds(TCD)and expelling phlegm compounds(TCD)on knee joint function and the synovial fluid concentration of cartilage oligomeric matrix protein in patients with knee osteoarthritis
作者:
王学宗1郑昱新1曹月龙2顾新丰1庞坚2詹红生2
1.上海中医药大学附属曙光医院,上海 201203;
2.上海市中医药研究院骨伤科研究所,上海 201203
Author(s):
Wang Xuezong*Zheng YuxinCao YuelongGu XinfengPang JianZhan Hongsheng.
*Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China
关键词:
骨关节炎膝 软骨寡聚基质蛋白 关节功能 柔肝 祛痰 治疗临床研究性
Keywords:
Osteoarthritisknee Cartilage oligomeric matrix protein Joint function Nourishing liver Expelling phlegm Therapiesinvestigational
摘要:
目的:比较柔肝和化痰中药复方对膝骨关节炎患者膝关节功能及关节液软骨寡聚基质蛋白浓度的影响及其安全性。方法:将61例符合要求的膝骨关节炎患者随机分为2组,Ⅰ组32例,Ⅱ组29例。Ⅰ组患者口服柔肝中药复方治疗,Ⅱ组口服化痰中药复方治疗。分别于治疗前和治疗4周后采用酶联免疫吸附法测定患者膝关节液中软骨寡聚基质蛋白的浓度,并采用自拟的膝关节功能评分量表评定患者的膝关节功能,同时观察记录2组患者治疗期间的不良反应发生情况。结果:①关节液COMP浓度测定结果。治疗前2组患者膝关节液中软骨寡聚基质蛋白浓度比较,差异无统计学意义[(4.35±1.42)ng·mL-1,(4.77±1.74)ng·mL-1,t=1.437,P=0.601]; 治疗后2组患者膝关节滑液中软骨寡聚基质蛋白浓度均降低[(4.21±1.66)ng·mL-1,(3.51±1.25)ng·mL-1],Ⅱ组降低程度更明显[(0.35±0.12)ng·mL-1,(1.05±0.09)ng·mL-1,t=4.024,P=0.038]。②膝关节功能评定结果。治疗前2组患者膝关节功能评分比较,差异无统计学意义[(20.63±4.89)分,(19.94±4.92)分,t=1.458,P=0.546]; 治疗后2组患者膝关节功能评分均降低[(9.25±3.01)分,(9.13±2.83)分],2组治疗前后降低程度比较,差异无统计学意义[(10.54±4.15)分,(9.97±4.07)分,t=1.913,P=0.205]。③不良反应评定结果。2组患者治疗期间均未发生与药物相关的不良反应。结论:与柔肝中药复方相比,化痰中药复方能更好地抑制膝骨关节炎患者软骨寡聚基质蛋白分泌,但二者改善膝关节功能的作用及其安全性相当。
Abstract:
To compare nourishing liver compounds(TCD)with expelling phlegm compounds(TCD)in the safety and effect on knee joint function and the synovial fluid concentration of cartilage oligomeric matrix protein(COMP)in patients with knee osteoarthritis.Methods:Sixty-one patients with knee osteoarthritis were included into the study and were randomly divided into 2 groups,32 patients in groupⅠwere administrated with nourishing liver compounds(TCD),while the others in groupⅡwere administrated with expelling phlegm compounds(TCD).The synovial fluid concentration of COMP were detected by enzyme-linked immunosorbent assay before the treatment and 4 weeks after the treatment respectively,and the knee joint functions were evaluated according to the self-designed knee joint function scale.Meantime,the adverse reactions were observed and recorded.Results:There was no statistical difference in the concentration of COMP in synovial fluid between the 2 groups before the treatment(4.35+/-1.42 vs 4.77+/-1.74 ng/mL,t=1.437,P=0.601),while the COMP concentration decreased in both of the 2 groups after the treatment,and the COMP concentration decreased more significantly in the groupⅡ(0.35+/-0.12 vs 1.05+/-0.09 ng/mL,t=4.024,P=0.038).There was no statistical difference in knee joint functional scores between the 2 groups before the treatment(20.63+/-4.89 vs 19.94+/-4.92 points,t=1.458,P=0.546),while the knee joint function scores decreased in both of the 2 groups after the treatment(9.25+/-3.01 vs 9.13+/-2.83 points),and there was no statistical difference between the 2 groups in the degree of decrease in knee joint function scores(10.54+/-4.15 vs 9.97+/-4.07 points,t=1.913,P=0.205).No adverse reactions related to drugs were found during the treatment in both of the 2 groups.Conclusion:For patients with knee osteoarthritis,nourishing liver compounds(TCD)and expelling phlegm compounds(TCD)have similar effects in improving the knee joint function,and they are similar to each other in safety,while the latter is more helpful to inhibit the secretion of COMP.

参考文献/References:

[1] 曹月龙,卫晓恩,庄志杰,等.膝骨性关节炎患者关节液透明质酸含量变化及关节功能状态的观察[J].中医正骨,2008,20(9):7-8.
[2] 郑广程,郑海伟,张国辉,等.玻璃酸钠关节腔注射配合小针刀松解治疗膝骨关节炎疗效观察[J].中医正骨,2012,24(1):15-17.
[3] 朱台航,蔡春元,张雷.骨关节炎生物标记物COMP的研究进展[J].中国骨伤,2010(12):959-961.
[4] 曹月龙,冯伟,王翔,等.柔肝中药对体外培养软骨细胞增殖能力及关节软骨低聚基质蛋白分泌的影响[J].中华风湿病学杂志,2007,11(8):469-472.
[5] 韩大鹏,郑昱新,石关桐,等.化痰中药对C57黑鼠膝骨关节炎滑膜中COMP表达的影响[J].中国中医骨伤科杂志,2007,15(8):9-12.
[6] 张鹏,石关桐,郑昱新,等.补肾方、柔肝方与化痰方对膝骨关节炎滑膜细胞增殖及COMP表达的影响[J].中国中医骨伤科杂志,2008,6(12):18-21.
[7] 王玉明,张胜昔.养血柔肝法治疗女性膝骨关节炎130例[J].北京中医,2006,25(11):666-668.
[8] 齐立卿,王金榜,杜双庆.养元柔肝汤治疗膝骨关节炎183例疗效观察[J].河北中医药学报,2009,24(3):14-15.
[9] 刘定安,雷波,杨少锋.化痰软坚法治疗骨性关节病35例报告[J].中国中医骨伤科,1998,6(2):40-41.
[10] Moskowitz RW,Altman RD,Hochberg MC.骨关节炎诊断与治疗[M].4版.北京:人民卫生出版社,2008:8.
[11] Hochberg MC,Altman RD,Brandt KD,et al.Guidelines for the medical management of osteoarthritis.PartⅡ.Osteoarthritis of the knee.American College of Rheumatology[J].Arthritis Rheum,1995,38(11):1541-1546.
[12] 张琼,肖京,邓磊.麝香通痹巴布膏治疗骨性关节炎(肝肾不足,筋脉瘀滞证)的临床研究[J].中国临床药理学与治疗学,2005,10(8):953-956.
[13] 曹月龙,庞坚,石瑛,等.管窥骨关节炎“痹痿并存”[J].上海中医药杂志,2011,45(11):50.
[14] 庞坚,石印玉,曹月龙,等.膝骨关节炎中医观的再认识[J].上海中医药大学学报,2011,25(1):26-28.
[15] Dodge GR,Hawkins D,Boesler E,et al.Production of cartilage oligomeric matrix protein(COMP)by cultured human dermal and synovial fibroblasts[J].Osteoarthritis Cartilage,1998,6(6):435-440.
[16] 郑昱新,曹月龙,石关桐,等.氨基葡萄糖对体外培养人软骨和滑膜细胞软骨寡聚基质蛋白分泌影响的比较[J].中华风湿病学杂志,2009,13(5):331-332.
[17] 沈培芝,汪青春,徐宇,等.益肾、健脾和柔肝中药抗炎镇痛作用的比较研究[J].中国中医骨伤科,1999,7(3):8-10.
[18] 石关桐,韩大鹏,郑昱新,等.补肾和柔肝中药对C57黑鼠膝骨关节炎滑膜中COMP基因表达的影响[J].上海中医药大学学报,2007,21(3):55-58.

相似文献/References:

[1]孟维娜,明立功,王新德,等.关节镜下清理联合腓骨近1/3段截骨治疗膝骨关节炎[J].中医正骨,2015,27(11):40.
[2]明立功,孟维娜,王新德,等.腓骨近端截骨治疗内侧间室膝骨关节炎的近期疗效观察[J].中医正骨,2015,27(10):25.
[3]张杰,王人彦,张玉柱.膝骨关节炎的治疗进展[J].中医正骨,2015,27(10):68.
[4]梁朝,蔡静怡,闫立,等.针刀疗法改善膝骨关节炎早期疼痛症状的疗效评价[J].中医正骨,2015,27(09):9.
 LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):9.
[5]王建武,党建军,李强,等.四联疗法治疗膝骨关节炎[J].中医正骨,2015,27(08):44.
[6]刘红娟,郭会利,郭树农.云克联合中药治疗膝骨关节炎的护理[J].中医正骨,2015,27(08):75.
[7]陈卫衡.探索建立系统的膝骨关节炎中医临床科研范式 和理论体系[J].中医正骨,2015,27(07):1.
[8]郑春松,叶蕻芝,李西海,等.透骨消痛胶囊中补肾柔肝药和活血祛风药治疗 骨关节炎作用方式的计算机模拟比较[J].中医正骨,2015,27(07):6.
 ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(补肾柔肝)drugs versus Huoxue Qufeng(活血祛风)drugs contained in Tougu Xiaotong Jiaonang(透骨消痛胶囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):6.
[9]帅波,沈霖,杨艳萍,等.加味青娥丸治疗膝骨关节炎的作用机制研究[J].中医正骨,2015,27(07):15.
 SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):15.
[10]梅其杰,袁长深,段戡,等.壮药骨痹方烫熨联合运动疗法治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(07):27.
 MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):27.

备注/Memo

备注/Memo:
基金项目:国家十一五支撑计划项目(2007BAI20B033),“中医骨伤科学”国家重点学科项目(100508),“海派中医流派传承研究基地”项目(ZYSNXD-CC-HPGC-JD-001),上海市教委项目(08cz025),上海市科委重点科技攻关项目(11DZ1972902)
通讯作者:郑昱新 E-mail:sg_zyx1728@126.com
更新日期/Last Update: 2014-01-20